Cargando…
A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability
The transcription factor and tumor suppressor protein p53 is the most frequently mutated and inactivated gene in cancer. Mutations in p53 result in deregulated cell proliferation and genomic instability, both hallmarks of cancer. There are currently no therapies available that directly target mutant...
Autores principales: | Guiley, Keelan Z., Shokat, Kevan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827106/ https://www.ncbi.nlm.nih.gov/pubmed/36197521 http://dx.doi.org/10.1158/2159-8290.CD-22-0381 |
Ejemplares similares
-
Chemoselective Covalent
Modification of K-Ras(G12R)
with a Small Molecule Electrophile
por: Zhang, Ziyang, et al.
Publicado: (2022) -
Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
por: Zhang, Ziyang, et al.
Publicado: (2022) -
Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines
por: Baud, Matthias G.J., et al.
Publicado: (2018) -
Harnessing Fluorine–Sulfur Contacts and Multipolar
Interactions for the Design of p53 Mutant Y220C Rescue Drugs
por: Bauer, Matthias R., et al.
Publicado: (2016) -
Discovery of Nanomolar-Affinity
Pharmacological Chaperones
Stabilizing the Oncogenic p53 Mutant Y220C
por: Stephenson Clarke, Joseph R., et al.
Publicado: (2022)